Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (13)

Trial Status

Completed6
Unknown2
Terminated2
Recruiting2
Active Not Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (13)

Research Network

Activity Timeline